Our timeline visualizes AI company exits valued at $1B+ at acquisition or IPO, including electric AV company NIO's public offering and Roche's massive acquisition of cancer tech company Flatiron Health.
Artificial intelligence is a sector that attracts big investor checks: Q2’19 recently saw record quarterly funding to AI startups at $7.4B. This included several $100M+ mega-deals to companies like robotic process automation company UiPath and AI-powered insurance startup Lemonade.
It’s also a sector that produces some very valuable exits.
Since 2013, 7 AI companies have exited via IPO or M&A valued at $1B+ — four of which have taken place in the last 2 years. Using CB Insights data, we visualized these 7 exits together in one timeline.
Our analysis considers first exits only. For more on billion-dollar exits, see Visualizing Tech Giants’ Billion-Dollar Acquisitions.
Please click to enlarge.
- NIO is the highest-valued exit on our list. The Shanghai-based electric autonomous vehicle manufacturer went public on the NYSE at a valuation of $6.4B in September 2018. Notably, NIO still ranks as third on the list of top-funded AI startups ever, with $2.2B in pre-exit equity funding.
- The highest-valued M&A deal on our list goes to cancer-focused healthcare startup Flatiron Health. Pharma giant Roche Holdings acquired the company in early 2018, valuing it at upwards of $2.1B.
- 3 companies on our list reached unicorn valuations prior to exiting: NIO ($5B), Mobileye ($1.5B), and Flatiron Health ($1.3B).
- Auto was a popular focus for many companies on our list. NIO and GM’s Cruise both focus on autonomous vehicles, while Mobileye develops advanced driver assistance systems.
|Company||Valuation at Exit ($M)||Exit Type|
|Flatiron Health||$2,125||Acquisition (Roche)|
|Cray||$1,300||Acquisition (Hewlett Packard)|